US FDA: Johnson & Johnson's one-shot COVID-19 vaccine safe and effective in trials

The one-shot COVID-19 vaccine developed by Johnson & Johnson appeared effective and safe in the latest trials, the US Food and Drug Administration (FDA) announced in a document published on Wednesday, as reported by Reuters.

"The FDA's panel of independent experts meets on Friday to decide whether to approve the shot," Reuters noted. "While it is not bound to follow the advice of its experts, the FDA did so when authorizing the Pfizer Inc and Moderna Inc vaccines."

Market reaction

The market mood remains upbeat following this headline and the S&P 500 Futures were last seen gaining 0.38% on the day at 3,892.